Leadership & About Us
SC Therapeutics is a Boston-based biopharmaceutical company founded in 2019 by Harvard Professor David Edwards dedicated to improving human respiratory and cardiovascular health by deactivating mechano-sensitive channels in the upper airways.
With offices at Suite 400, 214 Cambridge Street, Boston MA 02114.
“SC Therapeutics is pioneering understanding of and treatment modalities for a previously poorly understood inflammatory pathway in the upper airways that appears to broadly impact the human condition."
Dennis Ausiello, MD
Physician-in-Chief, Emeritus
Massachusetts General Hospital
Jackson Professor of Clinical Medicine, Emeritus
Harvard Medical School
Leadership
David Edwards
CEO & Founder
Pioneering aerosol scientist, inventor, founder of AIR. Harvard University Professor 2002–2019, Adjunct Professor Johns Hopkins Medical School (since 2024). Member of 3 National Academies.
Alka Batycky
COO
Biopharmaceutical executive with over 25 years of global drug development experience spanning early development through regulatory approval and launch. Previously worked at GSK, Alkermes, and AMAG Pharmaceuticals.
Lloyd Johnston
CTO
Highly accomplished executive with over 25 years of GMP manufacturing and CMC experience. Led successful development of multiple products from IND through Phase 3 and commercial success, including AIR, Alkermes, and Selecta.
Nancy Hargreaves
CFO
Senior finance executive and CFO with over 25 years experience working with company leadership teams. Previously CFO at Recros Medica, Inc. and Ionetix Inc., and VP, Business Intelligence at Invuity Inc.
Joe Anisko
Head of Quality & Regulatory (acting)
Dr. Anisko brings more than 30 years of experience in quality and regulatory positions with some of the world’s leading pharmaceutical companies, including AstraZeneca, Johnson & Johnson, Fisons, and Schering-Plough.